[Sceptic] every new three-letter analog needs a data table before a hype thread
Posting this as a discussion rather than a claim: every new three-letter analog needs a data table before a hype thread.
Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.
Net peptide content accounts for counterion, water and residual solvent. On some of these compounds the gap between purity and net content is substantial and entirely honest.
Purity methods differ by compound class. A gradient and wavelength developed for one peptide will not necessarily resolve the relevant impurities of another.
Corrections welcome, especially the pedantic ones. Pedantry is how this board earns its reputation.
best — the order this archive was captured in
Naming in this space is inconsistent. Several widely used names map to more than one molecule, so a catalogue number and a sequence beat a common name every time.
Agreed that thin testing here says something about the members, not about the material.
Storage conditions came back specific rather than generic when I asked. That told me somebody had actually done stability work.
Storage guidance that names a temperature, a state and a duration reflects actual stability work. Generic guidance usually reflects a template.
Agreed — identity first for anything off the well-travelled list. The purity number is meaningless until you know what it is pure of.
Has anyone here tested that compound at all?
Independent result added to the log — there are very few on that compound.
On the thin testing history in this board, and what to do about it.
Most of the compounds discussed here have a handful of independent results across the entire site, and several have none. That is a fact about how few members have paid for testing, not a judgement about the material.
What follows: buy small, test identity first for anything unusual, and post the result even when it is unremarkable. The vendor source pages are built from exactly these submissions, and the compounds with the thinnest coverage are the ones where one more entry changes the picture most. Research material is not approved for human use, so what this board can usefully build is an analytical record.
Cosigning the lead-time point. Made-to-order and stocked are completely different propositions and both are legitimate.
research-use-only material is not approved for human use
the same name covers several different molecules in this space
Yes. Naming conventions in this corner are loose enough that the same word covers several different molecules.
Small fix — that is net peptide content, not purity. Both are on the certificate and they differ substantially here.
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
net peptide content is where the surprises live
the sequence is the product, everything else is packaging
identity before purity, every time, for anything unusual
ask which lines are actually stocked rather than made to order
Net peptide content on the certificate was well below the purity figure and both were honest. Chemistry, not deception.
Research-use-only material is not approved for human use. In this catalogue that covers essentially everything, which is why the board discusses material and analytics rather than outcomes.
Ordered under a name that turned out to cover two different molecules. Nobody’s fault but mine for not asking.
- 1Yes. Naming conventions in this corner are loose enough that the same word…10 comments in this branch · started by u/prior_auth_pain